Publication: Time for action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind

Heidari et al., have recently published an article on Time for action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind.

 

Summary: 

  • The COVID-19 pandemic has revealed persistent gender inequalities that exacerbate health inequities.
  • Sex and gender intersect with other variables such as age, race and ethnicity, and other health conditions, resulting in differential risks and outcomes of COVID-19.
  • Importantly, well-documented sex differences in vaccine-induced immune response and adverse events, alongside gendered factors related to vaccination programmes, may influence vaccine acceptance, access and uptake, further worsening inequities.
  • It is thus imperative that an intersectional gender lens be systematically applied to development and deployment of COVID-19 vaccines.
  • Integral to this approach is meaningful engagement of women at all levels to ensure that scientific, policymaking and programmatic decision-making processes benefit from their leadership, expertise and perspectives.
  • This article presents a rationale and recommended actions for incorporating sex and gender dimensions in current and future COVID-19 vaccine development and deployment efforts to fast-track an end to the pandemic in an equitable way.

 

To read the full paper and find out more about the recommended actions for incorporating sex and gender dimenesions in future research, please click here.

 

Full citation: Heidari S, Durrheim DN, Faden R, et al. Time for action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind. BMJ Global Health 2021;6:e006854. doi:10.1136/ bmjgh-2021-006854. Online available: https://gh.bmj.com/content/bmjgh/6/8/e006854.full.pdf.

 

Comments:

For adding and reading comments please sign up or log in